- Show all
- 1557
- 50th Anniversary
- Abortion
- Affordable Care Act
- Child and Adolescent Health
- CHIP
- Civil Procedure
- Civil Rights
- Coronavirus
- Cost-sharing
- Court Access
- COVID-19 Public Health Emergency
- Data Collection
- Defending Medicaid
- Demonstrations
- Disability Rights
- Doula Care
- Dual Eligible Beneficiaries
- Dually eligible
- Eligibility and Enrollment
- EPSDT
- Exchanges/Marketplaces
- Family Planning
- Federal and State Court Cases
- HCBS/LTSS
- Health Care Reform
- Health Care Refusals
- Health Disparities
- Health Reform
- HIV/AIDS and Sexual Health
- Home and Community Based Services
- Immigrant Health
- Language Access
- LGBTQ Health
- Litigation
- Managed Care
- Medi-Cal
- Medicaid
- Medicaid Awareness Month
- Mental Health
- Nondiscrimination
- Opioid Use Disorder
- Oral Health
- Pregnancy
- Prescription Drugs Marketplace
- Prescription Drugs Medicaid
- Privacy and Confidentiality
- Public Charge
- Public Health
- Reproductive Health
- Services
- Supreme Court
- Telehealth
- Waivers and Demonstrations
- Women's Health
- women's health
- June 11, 2021
Demanding Ascertainable Standards: Medicaid as a Case Study
Read moreState Medicaid agencies and their contractors are increasingly relying on preset guidelines or assessment tools or both to make coverage decisions. Problems arise when the use of these tools results in program enrollees and advocates being refused access to the standards and procedures that govern the operation of the…
- July 18, 2019
National Health Law Program Comments on D.C. 1115 Waiver Application
Read moreIn comments to the Department of Health and Human Services (HHS), The National Health Law Program urges HHS to reject the District of Columbia’s proposed Section 1115 Medicaid Behavioral Health Transformation Demonstration Program. As part of the demonstration, the District seeks to waive the Institutions for Mental Diseases (IMD)…
- March 7, 2016
NHeLP Comments to the Senate Finance Committee on the High Price of Prescription
Read moreNHeLP letter to the Senate Finance Committee in response to the request for public comment on policy issues including the financial impact of high prices of breakthrough drugs, data on prescription drug costs, and ensuring patient access, particularly for low income and vulnerable populations. Commments follow after an 18 month investigation…
- May 14, 2014
Health Advocate: Special Enrollment Periods
Read moreOver 8 million people are now covered by health insurance thanks to open enrollment in the federal and state healthcare marketplaces. But, what about those who missed out on the open enrollment? In certain circumstances, such as loss of insurance coverage or other life changes, they may be eligible…
